Background-Impaired vasodilator function is an early manifestation of coronary artery disease and may precede angiographic stenosis. It is unknown whether noninvasive assessment of coronary vasodilator function in patients with suspected or known coronary artery disease carries incremental prognostic significance. Methods and Results-A total of 2783 consecutive patients referred for rest/stress positron emission tomography were followed up for a median of 1.4 years (interquartile range, 0.7-3.2 years). The extent and severity of perfusion abnormalities were quantified by visual evaluation of myocardial perfusion images. Rest and stress myocardial blood flows were calculated with factor analysis and a 2-compartment kinetic model and were used to compute coronary flow reserve (coronary flow reserve equals stress divided by rest myocardial blood flow). The primary end point was cardiac death. Overall 3-year cardiac mortality was 8.0%. The lowest tertile of coronary flow reserve (Ͻ1.5) was associated with a 5.6-fold increase in the risk of cardiac death (95% confidence interval, 2.5-12.4; PϽ0.0001) compared with the highest tertile. Incorporation of coronary flow reserve into cardiac death risk assessment models resulted in an increase in the c index from 0.82 (95% confidence interval, 0.78 -0.86) to 0.84 (95% confidence interval, 0.80 -0.87; Pϭ0.02) and in a net reclassification improvement of 0.098 (95% confidence interval, 0.025-0.180). Addition of coronary flow reserve resulted in correct reclassification of 34.8% of intermediate-risk patients (net reclassification improvementϭ0.487; 95% confidence interval, 0.262-0.731). Corresponding improvements in risk assessment for mortality from any cause were also demonstrated. Conclusion-Noninvasive quantitative assessment of coronary vasodilator function with positron emission tomography is a powerful, independent predictor of cardiac mortality in patients with known or suspected coronary artery disease and provides meaningful incremental risk stratification over clinical and gated myocardial perfusion imaging variables. (Circulation. 2011;124:2215-2224.)
T raditional approaches for cardiac risk assessment in coronary artery disease (CAD) include information about left ventricular (LV) function, the angiographic extent and severity of epicardial coronary stenoses, and the magnitude of inducible myocardial ischemia by noninvasive testing. 1 Although very powerful, these traditional risk markers together do not account fully for the risk of cardiac death, especially among high-risk subgroups. 2, 3 This suggests that other mechanisms may contribute to clinical risk. One such mechanism may involve the adverse effects of atherosclerosis and its risk factors on coronary epicardial and microcirculatory function, thereby increasing the potential for ischemic and atherothrombotic complications.
Clinical Perspective on p 2224
Coronary circulatory dysfunction is present in the earliest stages of atherogenesis and precedes significant angiographic stenosis, 4, 5 identifiable perfusion deficits, and wall motion abnormalities with traditional imaging methods. 6 -8 Furthermore, abnormalities in vascular function identified by specialized invasive methods have been shown to identify patients at increased risk for adverse cardiovascular events 9 -11 and to improve selection of patients for revascularization. 12 Coronary vasodilator function can also be assessed noninvasively with positron emission tomography (PET).
This study was designed to test the hypothesis that among patients referred for cardiac testing, abnormalities of coronary vasodilator function add incremental value for the identification of those at risk of cardiac death beyond clinical risk factors and traditional semiquantitative assessment of myocardial ischemia and LV function.
Methods

Study Population
All patients referred for rest/stress cardiac PET at the Brigham & Women's Hospital (Boston, MA) between January 1, 2006, and June 30, 2010, were included in this study, excluding those whose images were missing or uninterpretable owing to poor image quality. In cases of repeat evaluations during the study period, only the earliest evaluable study was included. The study was approved by the Partners Healthcare Institutional Review Board and conducted in accordance with institutional guidelines.
Risk Factor Assessment
Demographic factors and key elements of the patient's history, including risk factors and medication use, were ascertained at the time of the study by patient interview and review of medical records.
PET Imaging
Patients were studied with a whole-body PET-computed tomography scanner (Discovery RX or STE LightSpeed 64, GE Healthcare, Milwaukee, WI) after an overnight fast. Patients refrained from caffeine-and methylxanthine-containing substances and drugs for 24 hours before their scans. Myocardial blood flow (MBF) was measured during rest and peak stress with rubidium-82 as a perfusion tracer, as described previously. 13 Briefly, after transmission imaging and beginning with the intravenous bolus administration of rubidium-82 (1480 -2200 MBq), list mode images were acquired for 7 minutes. Then, a standard intravenous infusion of dipyridamole, adenosine, regadenoson, or dobutamine was given. At peak stress, a second dose of rubidium-82 was injected, and images were recorded in the same manner. The average radiation exposure per study was 4.6 mSv. 14 Heart rate, blood pressure, and 12-lead ECG were recorded at baseline and every minute during and after pharmacological stress.
Image Analysis
Semiquantitative Analysis of Myocardial Perfusion
Semiquantitative 17-segment visual interpretation of the gated myocardial perfusion images was performed by experienced observers using a standard 5-point scoring system. 15 Summed rest and stress scores were calculated as the sum of individual segmental scores on the respective images, and their difference was recorded as summed difference score. For each of these variables, higher scores reflect larger areas of myocardial ischemia and/or scar. Summed rest, stress, and difference scores were converted into percentages of total myocardium by division of the maximum possible score.
LV Systolic Function
Rest and stress LV ejection fractions (LVEFs) were calculated from gated myocardial perfusion images with commercially available software. LVEF reserve was considered present when LVEF increased from rest to stress.
Quantitative MBF and Flow Reserve
Absolute MBF (in mL ⅐ g Ϫ1 ⅐ min Ϫ1 ) was computed from the dynamic rest and stress imaging series with commercially available software (Corridor4DM; Ann Arbor, MI) and previously validated methods. 13, 16 Automated factor analysis was used to generate blood pool (arterial input function) and tissue time-activity curves. 17 Regional and global rest and peak stress MBFs were calculated by fitting the rubidium-82 time-activity curves to a 2-compartment tracer kinetic model, as described previously. 16 Per-patient global coronary flow reserve (CFR) was calculated as the ratio of absolute MBF at stress over rest for the entire left ventricle. Quantification of MBF was performed by 4 operators. The intraclass correlation coefficient for CFR among these 4 readers was 0.94 (95% confidence interval [CI], 0.88 -0.98), indicating excellent reproducibility.
Assessment of Outcomes
The primary outcome was death resulting from any cardiac cause. Patients who died of noncardiac causes were censored. The vital status of all patients was ascertained by integrating data from the Social Security Death Index, the National Death Index, and the Partners Healthcare Research Patient Data Registry. Cause of death was determined by blinded adjudication of hospital records and death certificates. Early revascularization (within 90 days) was ascertained from the Partners Healthcare Research Patient Data Registry and hospital records. Mortality from any cause was used as a secondary end point.
Statistical Analysis
Statistical significance was assessed with Wilcoxon tests, Fisher exact tests, and 2 tests for continuous, dichotomous, and categorical variables, respectively. Two-sided values of PϽ0.05 were considered significant. All statistical analyses were performed with SAS 9.2 (SAS Institute Inc, Cary, NC).
Multivariable Modeling
The Cox proportional hazards model was used to assess the impact of CFR on cardiac mortality after controlling for the effects of critical covariates. A series of models were developed, starting with one containing only clinical covariates (ie, age, sex, hypertension, dyslipidemia, diabetes mellitus, family history of CAD, tobacco use, history of CAD [including recent or prior myocardial infarction and revascularization], body mass index, chest pain, dyspnea, and early revascularization). Rest LVEF, the combined extent of myocardial scar and ischemia, stress-induced LVEF augmentation, and CFR (in tertiles) were then sequentially incorporated into the model. To investigate the effects of absolute peak stress MBF, we generated an additional model containing absolute stress MBF instead of CFR. The models were examined for the validity of the proportional hazards assumption and additive value, taking care to avoid overfitting. Survival was plotted using direct adjusted survival probabilities 18 from the Cox survival model.
To assess for biases introduced by early revascularization, analyses were repeated, censoring all patients who underwent early revascularization. 19 In an exploratory analysis, we considered the effect of any revascularization, including those Ͼ90 days after the PET scan, as a time-dependent covariate.
Assessment of Incremental Value
Incremental prognostic value of CFR was assessed with the likelihood ratio test to determine the improvement in prediction power of each sequential Cox model. Model calibration was evaluated with the Nam-D'Agostino 2 statistic. 20 The c index was calculated for each model 21 with comparisons using the method of Antolini and colleagues. 22 The potential impact of CFR on risk stratification was assessed by net reclassification improvement (NRI) 23 at 1.5 years with the use of threshold annual rates of cardiac mortality of 1% and 3% based on American College of Cardiology/American Heart Association guidelines for the management of chronic stable angina. 1
Exploratory Analyses
The effect size of CFR on cardiac mortality was evaluated in a series of subgroups by constructing Cox proportional hazard models for each subgroup containing only CFR tertiles as predictor variables (ie, unadjusted models). Effect modification was explored with Cox models incorporating interaction terms between key covariates and CFR.
To explore the relative contribution of epicardial stenoses and microvascular dysfunction, findings on coronary angiography within 90 days of PET were correlated to CFR tertile among patients with no evidence of scar or ischemia by visual PET evaluation and without history of coronary artery bypass graft surgery or intervening myocardial infarction. Lesions Ͼ70% stenosis were considered significant. Angiographic disease was categorized as nonobstructive or normal (Ͻ50% stenosis) or 1-, 2-, or 3-vessel disease.
Results
Patient Characteristics
A total of 2783 of 3404 consecutive patients (81.8%) met inclusion criteria during the study period and were followed up for a median of 1.4 years (interquartile range, 0.7-3.2 24 The most common indications for testing were evaluation for chest pain, dyspnea, or their combination. Approximately half of all studies were normal by semiquantitative visual analysis. Scar and ischemia were more common in patients who experienced cardiac mortality. However, scar rather than ischemia accounted for a larger portion of defects among patients who died.
At rest, MBF was comparable across tertiles of CFR (1.17, 1.14, and 1.01 mL ⅐ g Ϫ1 ⅐ min Ϫ1 for patients in high, intermedi-ate, and low tertiles of CFR, respectively; PϽ0.0001; Figure 1 ). During peak stress, there was a significant stepwise decline in MBF with decreasing tertiles of CFR (2.61, 1.98, and 1.35 mL ⅐ g Ϫ1 ⅐ min Ϫ1 for patients in high, intermediate, and low tertiles of CFR, respectively; PϽ0.0001), indicating that reduced CFR reflected primarily a reduction in coronary vasodilator function.
Patient Outcomes
Mortality from any cause occurred in 279 patients (10.3%), 137 of which (49.1%) were due to cardiac causes ( Table 2) . Threeyear cardiac mortality was 8.0%. Compared with patients without cardiac death, those who experienced cardiac death were older, were more likely to be male with diabetes mellitus, had a lower body mass index, and were more likely to be referred for dyspnea evaluation and to have prior CAD, lower rest LVEF, and larger abnormalities on PET scans ( Table 1 ).
The annual rate of cardiac death increased with increasing myocardial scar and ischemia and decreasing CFR ( Figure  2A and 2B). Importantly, lower CFR consistently identified higher-risk patients at every level of myocardial scar/ischemia, including among those with visually normal PET scans. Likewise, in each category of LVEF, increasing tertiles of CFR were associated with a significant decrease in the risk of cardiac mortality ( Figure 2C ).
Univariate Predictors of Mortality
Compared with the highest tertile of CFR (values Ͼ2), the lowest tertile (values Ͻ1.5) was associated with a 16-fold increased risk, whereas the intermediate tertile was associated with a 5.7-fold increased risk for cardiac death. Other significant predictors of increased risk included age, male sex, renal failure requiring dialysis, and prior CAD ( Figure 3 ). Chest pain as a reason for testing and obesity was unexpectedly associated with a decreased risk, possibly reflecting confounding caused by more aggressive testing and treatment in these groups, although alternative mechanisms have been suggested for similar observations in other cohorts. 25 In addition, dyspnea, a decrease in rest LVEF, the absence of stress-induced LVEF augmentation, and an increasing burden of myocardial scar, ischemia, or their combination on semiquantitative visual analysis were all significantly associated with increased risk. COPD indicates chronic obstructive pulmonary disease; BMI, body mass index; CAD, coronary artery disease; ACE, angiotensinconverting enzyme; MI, myocardial infarction; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft; PET, positron emission tomography; LVEF, left ventricular ejection fraction; CFR, coronary flow reserve; and MBF, myocardial blood flow. Continuous variables are presented as median (interquartile range). Dichotomous variables are presented as number (%). Patients whose LVEF at stress was greater than that at rest were considered to have positive stress-induced increase in LVEF.
Multivariable Survival Analysis and Incremental Prognostic Value
A series of multivariable models were constructed to assess the incremental value of CFR after adjustment for critical covariates known to be associated with increased risk of cardiac mortality ( Table 3 ). Addition of CFR was associated with a significant increase in global 2 and decrease in Akaike information criterion, indicating improved model fit, and a significant increase in the c index from 0.82 to 0.84 (Pϭ0.02). Compared with the highest tertile of CFR, the adjusted hazard ratio for cardiac death was 5.6 (95% CI, 2.5-12.4; PϽ0.0001) for the lowest tertile and 3.4 (95% CI, 1.5-7.7; Pϭ0.003) for the intermediate tertile ( Figure 4) .
In contrast, replacement of CFR by peak stress MBF in a model containing clinical covariates, rest LVEF, the com-bined extent of myocardial scar and ischemia, and stressinduced LVEF augmentation resulted in a more modest increase in the global 2 from 227.3 to 230.6 (Pϭ0.07). The adjusted hazard ratio for cardiac death was 1.1 (95% CI, 1.0 -1.3; Pϭ0.07).
Risk Reclassification
The addition of CFR estimates to the model resulted in the reclassification of 15%, 48%, and 12% of patients at low, intermediate, and high cardiac risk, respectively, based on the pre-CFR model (model 4, Table 3 ; Figure 5 ). The NRI was 0.098 (95% CI, 0.025-0.180) across clinically meaningful risk categories of Ͻ1%, 1% to 3%, and Ն3% annual rate of cardiac death ( Table 4 ). The continuous NRI was 43.5% (95% CI, 23.9 -62.2). The benefit of CFR on risk reclassifi- Patients were divided into tertiles of coronary flow reserve (CFR) corresponding to Ͻ1.5, 1.5 to 2.0, and Ͼ2.0. 
Subgroup Analysis and Effect Modification
The impact of CFR on the risk of cardiac death was consistent across 29 of 33 subgroups evaluated ( Figure 6 ), suggesting the broad potential impact of this measure in clinical practice. Interaction terms between CFR and age, sex, and diabetes mellitus were nonsignificant, underscoring the consistent effect of CFR on cardiac mortality. Transient ischemic dilation has been associated with poor prognosis and severe disease on coronary angiography. Among 1883 patients (67.7%) for whom transient ischemic dilation was available, incorporation of transient ischemic dilation into a model containing clinical risk factors, LVEF, extent of ischemia, and scar-and stress-induced LVEF augmentation was not associated with an improved model fit, increase in c index, or positive NRI. However, the addition of CFR to the comprehensive model containing transient ischemic dilation continued to improve model fit (PϽ0.0001) and the c index (0.84 versus 0.86; Pϭ0.05) and was associated with favorable risk reclassification (NRIϭ0.068).
To assess the relative impact of epicardial stenosis and microvascular dysfunction on impaired CFR, we correlated CFR findings to angiographic findings in the 41 of 1444 patients (2.8%) with normal PET scans on semiquantitative visual assessment and no history of coronary artery bypass graft surgery who underwent coronary angiography within 90 days of their PET scan and did not have intervening myocardial infarction or revascularization. Nineteen of the 41 patients (46%) had nonobstructive disease by coronary angiography (Ͻ70% stenosis). Likewise, 12 of 25 patients with abnormal CFR (low or intermediate CFR tertiles) had no obstructive epicardial stenosis by angiography.
All-Cause Mortality
Analyses were repeated with mortality from any cause as a secondary outcome, and the results remained significant although somewhat attenuated. After correction for a wide array of risk factors, CFR remained a significant predictor of mortality with the lowest tertile of CFR associated with a hazard ratio of 2.82 (95% CI, 1.87-4.26; PϽ0.0001) compared with the highest tertile. Similarly, the middle tertile of CFR carried a hazard ratio of 1.79 (95% CI, 1.17-2.72; Table 3 ). The pie graphs represent the proportions of patients in each pre-CFR category reassigned to each risk category after the addition of CFR to the risk model (model 5, Table 3 ). The vertical bar charts at the bottom represent the annualized rates of cardiac mortality in each of the post-CFR risk categories.
Pϭ0.007) compared with the highest tertile. The continuous NRI for all-cause mortality was 0.408 (95% CI, 0.272-0.537). When thresholds of 2% and 6% annually for mortality from any cause were used, the NRI was 0.058 (95% CI, 0.006 -0.111).
Discussion
These data from a large patient cohort demonstrate the incremental prognostic value of noninvasive measures of CFR over the combination of comprehensive clinical assessment, LV systolic function, and semiquantitative measures of myocardial ischemia and scar for identification of patients at risk of cardiac mortality. Indeed, patients with the highest tertile of CFR, indicating preserved vasodilator function, had an extremely low rate of cardiac mortality (Ͻ0.5%/y). Conversely, intermediate CFR and severely reduced CFR were associated with an adjusted hazard ratio for cardiac mortality of 3.4 and 5.6, respectively. The addition of CFR to clinical variables, rest LVEF, LVEF reserve, and extent of myocardial scar and ischemia resulted in the correct reclassification of approximately one third of all intermediate-risk patients.
Prior Studies
Prior studies have evaluated the diagnostic value of CFR compared with coronary angiography and fractional flow reserve, especially with respect to detection of multivessel CAD. 27, 28 More recent studies have examined the prognostic value of noninvasive estimates of CFR in Ͻ700 patients with limited numbers of outcome events. 29 -32 Although these studies suggested an association between impaired CFR and adverse cardiovascular events (including hospitalization for cardiac causes and late revascularization), they were underpowered to demonstrate an association between impaired CFR and cardiac mortality. The demonstration of incremental prognostic value was also limited by incomplete adjustment for important markers of clinical risk 29, 31 and measures of LV systolic function. 30, 31 Our study included a large number of patients with known or suspected CAD encompassing a wide spectrum of clinical risk and was sufficiently powered to adjust for a broad array of clinical and imaging risk markers and to demonstrate an association between decreased CFR and risk of cardiac mortality. More important, the inclusion of CFR in risk prediction models resulted in the correct reclassification of risk in a substantial proportion of patients, including 35% of 
Mechanistic Link Between Abnormal Coronary Circulatory Function and Cardiac Mortality
The exact mechanism relating noninvasive measures of CFR to increased cardiac mortality cannot be determined from this study. However, several potential mechanisms could explain our findings. The observation that the reduction of CFR was due primarily to progressive reductions in peak stress MBF suggests a primary abnormality in coronary vasodilator function.
Because our study cohort included patients with both known and suspected CAD, it is likely that the observed abnormalities in coronary function integrate the fluid dynamic effects of epicardial stenosis with those of coronary risk factors and atherosclerosis on microcirculatory function. However, the fact that CFR improved risk stratification not only in the setting of demonstrable ischemia and/or scar, as identified by conventional methods, but also among those patients with visually normal PET scans suggests that diffuse atherosclerosis and vascular remodeling, microvascular dysfunction, or both may also partially account for the excess cardiac mortality among those with impaired CFR. Indeed, the fact that approximately half the patients with visually normal PET scans who underwent coronary angiography had nonobstructive CAD supports the notion that the observed excess coronary risk may be related in part to microvascular dysfunction. Such abnormalities have been described in early stages of atherogenesis in patients without overt CAD or angiographically normal coronary arteries 33 and have been linked to disease progression 10 and adverse cardiovascular events, including sudden cardiac death, myocardial infarction, congestive heart failure, and coronary revascularization. 9, 11, 34, 35 Limitations of our analyses merit consideration. The present study is a single-center, nonrandomized, observational study and carries all of the inherent limitations of that study design. Thus, it is likely that some amount of residual confounding remains, despite adjustment for a wide array of clinically relevant covariates. On the other hand, compared with data derived from patients selectively enrolled in a randomized trial, these data, with very limited exclusion criteria, may be more representative of patients seen in routine clinical practice.
Another side effect of our broad inclusion criteria is that we may understate the value of parameters that have previously been shown to be markers of poor prognosis in more restricted subgroups. 36 The breadth of the inclusion criteria of this study underscores the generalizability of the findings.
The demonstrated improvement in the c index is only moderate in size, especially compared with the more substantial impact on risk reclassification. However, this reflects the relative insensitivity of the c index 37 rather than the limited clinical value of CFR measures.
Peak stress blood flow on its own was a less powerful predictor of outcomes than CFR, possibly because CFR taken as the ratio of peak stress and rest blood flows may better isolate vasodilator capacity and reduce systematic errors in measurement.
Finally, we are not able to evaluate the downstream impact of CFR on patient management decisions because referring clinicians were not informed of CFR results in clinical reports. However, this reduces bias in estimates of CFR effect size introduced by subsequent treatment decisions based on this result.
Conclusion
Noninvasive assessment of coronary vasodilator function provides incremental risk stratification beyond routine measures of clinical risk, including estimates of LV systolic function and the extent and severity of myocardial ischemia and scar, and results in a meaningful incremental risk reclassification of patients with known or suspected CAD.
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